Cullinan Therapeutics, Inc.
CGEM · NASDAQ
Earnings history and estimates
Reported and estimated revenue, EPS and post-earnings movement.
| Period | Date | Revenue actual | Revenue estimate | EPS actual | EPS estimate | 1D move |
|---|---|---|---|---|---|---|
| 2026 Q2 | August 7, 2026 | — | 3.67M | — | -0.71 | — |
| 2026 Q1 | May 7, 2026 | — | 3.67M | -0.75 | -0.84 | — |
| 2025 Q4 | March 10, 2026 | — | 5.00M | -0.77 | -0.80 | -3.30% |
| 2025 Q3 | November 6, 2025 | — | 5.56M | -0.77 | -0.95 | -2.18% |
| 2025 Q2 | August 7, 2025 | — | — | -1.07 | -0.83 | — |
| 2025 Q1 | May 8, 2025 | — | — | -0.74 | -0.78 | — |
| 2024 Q4 | February 27, 2025 | — | — | -0.73 | -0.75 | — |
| 2024 Q3 | November 7, 2024 | — | — | -0.69 | -0.78 | — |
| 2024 Q2 | August 8, 2024 | — | — | -0.75 | -0.73 | +2.38% |
| 2024 Q1 | May 15, 2024 | — | — | -0.86 | -0.90 | -2.69% |
| 2023 Q4 | March 14, 2024 | — | — | -0.54 | -0.96 | -5.80% |
| 2023 Q3 | November 8, 2023 | — | — | -0.91 | -0.91 | +8.21% |
| 2023 Q2 | August 10, 2023 | — | — | -0.82 | -0.99 | -0.68% |
| 2023 Q1 | May 11, 2023 | — | — | -1.42 | -0.84 | -8.15% |
| 2022 Q4 | March 9, 2023 | — | — | -0.59 | -0.65 | — |
| 2022 Q3 | November 14, 2022 | — | — | -0.54 | -0.97 | -2.74% |